FDA Publishes Summary Report of Pediatric Meropenem Studies and Requests Labeling Changes

Summary

The Food and Drug Administration (FDA) is publishing a summary report of pediatric studies of meropenem conducted in accordance with the Public Health Service Act (PHS Act), and is making available requested labeling changes for meropenem. The Agency is making this information available consistent with the PHS Act.